跳至主要内容
临床试验/NCT00486304
NCT00486304已完成1 期

Phase I Randomized, Double-blind, Placebo-controlled Trial of the Effect of Temporary Dietary Antioxidant Depletion on Tumor Growth and Cachexia in Head and Neck Cancer Patients Receiving Chemoradiation Therapy

UNC Lineberger Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2006年2月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
4
试验地点
1
主要终点
Number of people with adverse events

研究概览

简要总结

RATIONALE: Eating a diet that is low in antioxidants may control cachexia in patients with oropharyngeal cancer.

PURPOSE: This randomized phase I trial is studying the side effects of a low antioxidant diet in controlling cachexia in patients with oropharyngeal cancer receiving chemotherapy and radiation therapy.

详细描述

OBJECTIVES:

Primary

  • Determine the safety of the antioxidant-deficient diet (ADD) in controlling cachexia in patients with oropharyngeal cancer receiving chemoradiotherapy.

Secondary

  • Determine the safety of the ADD as measured by quality of life, peripheral DNA damage, and change in body weight.
  • Determine the effectiveness of the ADD on tumor growth and surrogate markers of tumor growth.
  • Determine whether the ADD is effective in improving the tumor cachexia syndrome in these patients.
  • Determine whether there is a serum metabolomic signature for the ADD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Biopsy-proven carcinoma of the oropharynx (regardless of primary diagnosis or recurrence)
  • •No active treatment for disease within the past 4 weeks
  • •PATIENT CHARACTERISTICS:
  • •Not pregnant or nursing
  • •Negative pregnancy test
  • •Fertile patients must use effective contraception
  • •Feeding tubes allowed
  • •Prior malignancies allowed provided all of the following criteria are met:
  • •Patient has undergone potentially curative therapy for all prior malignancies
  • •There has been no evidence of any prior malignancies within the past 5 years (except for successfully treated cervical or non-melanoma skin cancer with no evidence of recurrences)
  • •Patient is deemed by their treating physician to be at low risk for recurrence from prior malignancies
  • •Must be able to speak English
  • •Must have adequate home refrigeration
  • •No intractable vomiting
  • •No ascites or clinical/ultrasound evidence of fluid retention
  • •No uncontrolled hypertension
  • •No severe congestive heart failure
  • •No pneumonia
  • •No severe infections
  • •No known HIV positivity
  • •No coexisting medical condition that would preclude study compliance
  • •No decisionally-impaired individuals
  • •No history of abetalipoproteinemia (Bassen-Kornzweig syndrome)
  • •No history of spinocerebellar ataxia
  • •No history of chronic cholestatic hepatobiliary disease
  • •No history of diagnosed vitamin E deficiency
  • •No history of protein-energy malnutrition (marasmus or kwashiorkor)
  • •No history of disorders related to malabsorption (e.g., celiac disease, sprue, cystic fibrosis, duodenal bypass, congenital partial obstruction of the jejunum, obstruction of the bile ducts, giardiasis, or cirrhosis)
  • •No history of achlorhydria
  • •PRIOR CONCURRENT THERAPY:
  • •See Disease Characteristics
  • •No concurrent parenteral nutrition

排除标准

  • 未提供

研究组 & 干预措施

Antioxidant-deficient diet (ADD)

Experimental

干预措施: ADD (Other)

Placebo

Placebo Comparator

干预措施: Placebo (Other)

结局指标

主要结局

Number of people with adverse events

时间窗: 70 days

Estimate the safety of the antioxidant-deficient diet (ADD) by measuring the frequency of grade 3 or 4 adverse events, per CTCAE criteria

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验